These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22493979)

  • 41. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance.
    Fan J; To KKW; Chen ZS; Fu L
    Drug Resist Updat; 2023 Jan; 66():100905. PubMed ID: 36463807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell Migration Related to MDR-Another Impediment to Effective Chemotherapy?
    Kryczka J; Boncela J
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
    Dlugosz A; Janecka A
    Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux.
    Willers C; Svitina H; Rossouw MJ; Swanepoel RA; Hamman JH; Gouws C
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):1949-1976. PubMed ID: 31292714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of sildenafil in enhancing drug sensitivity in cancer.
    Shi Z; Tiwari AK; Patel AS; Fu LW; Chen ZS
    Cancer Res; 2011 Jun; 71(11):3735-8. PubMed ID: 21610107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marine Natural Products as Models to Circumvent Multidrug Resistance.
    Long S; Sousa E; Kijjoa A; Pinto MM
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters.
    Chen Z; Ling K; Zhu Y; Deng L; Li Y; Liang Z
    Gene; 2020 Oct; 759():145000. PubMed ID: 32717310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.
    Teodori E; Braconi L; Manetti D; Romanelli MN; Dei S
    Curr Top Med Chem; 2022; 22(31):2535-2569. PubMed ID: 36284399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.
    Anreddy N; Gupta P; Kathawala RJ; Patel A; Wurpel JN; Chen ZS
    Molecules; 2014 Sep; 19(9):13848-77. PubMed ID: 25191874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zinc finger proteins and ATP-binding cassette transporter-dependent multidrug resistance.
    Barzegar S; Pirouzpanah S
    Eur J Clin Invest; 2024 Feb; 54(2):e14120. PubMed ID: 37930002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
    Begicevic RR; Falasca M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.
    Arrigoni E; Galimberti S; Petrini M; Danesi R; Di Paolo A
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1419-1432. PubMed ID: 27459275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer.
    Bharathiraja P; Yadav P; Sajid A; Ambudkar SV; Prasad NR
    Drug Resist Updat; 2023 Nov; 71():101004. PubMed ID: 37660590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters.
    Sajid A; Rahman H; Ambudkar SV
    Nat Rev Cancer; 2023 Nov; 23(11):762-779. PubMed ID: 37714963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing "Generally Recognized As Safe" (GRAS) nanopharmaceuticals: A review.
    Sosnik A
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1828-51. PubMed ID: 24055628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
    Deng J; Shao J; Markowitz JS; An G
    Pharm Res; 2014 Sep; 31(9):2237-55. PubMed ID: 24842659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.